Member Info for mazik

The RNS of 3rd December is due to come to play for holders, as Nigel refered Demonstrating that Nuvec® loaded with a plasmid DNA can be dried, stored at convenient temperatures and reconstituted without any drop in transfection is a significant step forward in our formulation development work
"The recent success of Pfizer and Moderna with an mRNA Covid-19 vaccine shows the potential for nucleic acid vaccines. However, it also highlights that these vaccines have certain limitations, in that they often require extreme storage .condition
"Although vaccine efficacy is predominantly determined by the selected nucleic acid antigen, having a stable, easy to store and easy to use vaccine is crucial in helping vaccine acceptance and uptake. A formulation stable at room temperature or even refrigerated can represent significant cost savings in vaccine transportation, storage and administration. We believe, to the extent that Nuvec® as a delivery platform can provide a solution in this area, it could be of significant interest to multiple vaccine developers.

Rick thank u, potential is high here due to the demand of specialist product Hayd has been producing and approved . Imo

Hayd is undervalued, with approved washable and reuseable Gramphene mask, the potential is very high market cap should be multiples of todays price IMO...compared to others like RMS full of hot air

Well a unique opportunity for the New Year, Market Cap under £20 M, whilst RMS with nothing but only idea and hot air mcap £48m

Lorry driver is buying at this silly price , he has sent application to join in as director

High potential, cash £3.5 million, mentioned about potential partnership And collaboration with Vaccine makers

Glad he is not going on about masked dongle.

They want your shares :-)With vaccines and their delivery very much in the public consciousness we continue to grow our data package to present Nuvec(R) as a viable delivery technology solution to improve the delivery, storage and transportation of multiple existing and new vaccines.
"Whilst we are well funded for all existing work streams these additional funds will enable us to plan for follow on studies and more product focussed experiments as we move towards collaborations."

Very strange , any positive remark is being deleted...anyone could highlight me..is it LSE,s policy about something I dont know:-)

Load now , as partnership RNS likely ..gla

The Directors believe that demonstrating Nuvec® can be consistently formulated with DNA or mRNA and dry stored for later use would give Nuvec® a considerable commercial advantage as a delivery technology compared to lipid based mRNA systems that require substantial freezing or electroporation based DNA systems which are expensive and difficult to use. As this work concludes the Company will look to incorporate the key findings into the planned optimised in vivo study.
The above statement is a big advantage to a pharma IMO

Production and orders RNS will initiate a new valuation... Holding until we get the potential in front of us, maybe 20p plus

Wow! all rocket set in Derby..Luke has the job to press the button....Viagra has worked....

Buy before it is over 10p ..imo All rockets positioned :-)

Enormous potential if we read the RNS of 5th November "The Directors believe that demonstrating Nuvec® can be consistently formulated with DNA or mRNA and dry stored for later use would give Nuvec® a considerable commercial advantage as a delivery technology compared to lipid based mRNA systems that require substantial freezing or electroporation based DNA systems which are expensive and difficult to use. As this work concludes the Company will look to incorporate the key findings into the planned optimised in vivo study."

Thank u Leister and John about what we might expect in the coming days, it helps woogie and others expectation. .
My opinion is that its a bargain below the placing price until then we hope an update soon, to get it going Packet of Viagra on its way to N4p office in Derby for our illustrious Bod and unproven non exec Director. (Historian)

An update as indicated in the last RNS, is due Non-exec not seen any buying or chirping gives us any confidence, though time is right with Pfizer vaccine in knots, its time for Nigel to forge collaboration and prove Nuvec can solve the logistics. Update from, Evotec , Nanomerics might be just in the corner

Its a gas play now, low outlay. The £8 million Market cap is too low..IMO Angs continue to progress procurement of key processing equipment for the Saltfleetby Gas Field. They are aiming to secure only those items which require the greatest lead times in production, re-engineering or delivery, with only modest financial outlay.

Could it be a leak here ?l " Company has appointed KRE Corporate Recovery Limited ("KRE") to explore other remaining options to maximise value for creditors and potentially other stakeholders."

When we were at 2.25 early last year there was a RNS that there was several predators circling for a takeover held the share for 6 months and had to give up at 1.65.... I am in the impression that someone out there is going for a bargain, even 1.5 will be a bargain.. IMO